Industry

Positive Phase 1 Data Support Near-term Initiation of Global Phase 2 Trial CAMBRIDGE, Mass. & LAUSANNE, Switzerland–(BUSINESS WIRE)–Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced that data from the Phase 1 ACeD (Assessment of KAN-101 in Celiac Disease) clinical trial evaluating its lead candidate, KAN-101, … [Read more…]

SHANGHAI & SUZHOU, China & GERMANTOWN, Md.–(BUSINESS WIRE)–#SITC2022–Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide, today announced it will have five poster presentations at the SITC 2022 Annual Meeting being held in Boston, Massachusetts from November 8-12. The posters will highlight studies on five innovative … [Read more…]

Acquisition Creates One of the Nation’s Largest Specialty-Focused, Digital Point of Care Advertising Networks NEW YORK–(BUSINESS WIRE)–CheckedUp (or the “Company”), one of the leading providers of 100% digital healthcare solutions at the point of care, announced today that it has acquired Health Media Network (“HMN”), a provider of digital healthcare solutions and wellness content to … [Read more…]

neffy has potential to be the first non-injectable medicine indicated to treat allergic reactions (type I) including anaphylaxis in the U.S., if approved SEATTLE–(BUSINESS WIRE)–Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review ARS Pharmaceuticals, Inc.’s (ARS Pharma) New Drug Application (NDA) for neffy … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Circular Dichroism (CD) Spectrometers Market (2022-2027) by Product, End-user, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Circular Dichroism (CD) Spectrometers Market is estimated to be worth USD 51.43 million in 2022, and is expected to reach USD 71.56 million … [Read more…]

DALLAS–(BUSINESS WIRE)–$LTRN–Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) and machine learning (“M.L.”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that Lantern management will be presenting at the ThinkEquity Conference, which is being held on October 26th, … [Read more…]

October 28, 2022 at 1pm ET, 10am PT Shareholders are invited to submit questions to the CEO PEARL RIVER, N.Y.–(BUSINESS WIRE)–Acorda Therapeutics, Inc. (Nasdaq: ACOR) will hold a virtual, video Q&A with its CEO, Ron Cohen, M.D., on Friday, October 28 at 1:00pm ET, 10:00am PT. The call will review the items on the ballot … [Read more…]

This new compact system can fit in existing LINAC vaults, making proton therapy more accessible and affordable than ever before. LITTLETON, Mass.–(BUSINESS WIRE)–#ASTRO22–Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, today introduced its new product, the MEVION S250-FIT Proton Therapy System™. Enabled by the … [Read more…]

— Distribution partners stocked with product and ready to sell into estimated $2 billion market — BOSTON–(BUSINESS WIRE)–Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) (“Spectrum” or the “Company”), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the commercial availability of ROLVEDON™ (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile … [Read more…]

Grocer builds on long-standing partnership to aid vital patient care with help from generous Louisiana customers NEW ORLEANS–(BUSINESS WIRE)–Winn-Dixie is proud to announce a donation of $40,000 to the Ochsner Cancer Institute. Generous Winn-Dixie customers made donations at store locations throughout Louisiana to benefit crucial treatments offered by the healthcare institution. This contribution is made … [Read more…]